Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Handrean Soran, Central Manchester University Hospitals NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01054508
First received: January 21, 2010
Last updated: October 10, 2012
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)